REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
23/03/2026
Voltar para busca
Dado oficial do USPTO
EVOLVE BIOLOGICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000087717949Classe
5, 37, 40, 41, 42
Pedido
87717949
Registro
6297748
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
54
Atualização mais recente
24/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 37, 40, 41, 42
Data de depósito
12/12/2017
Data de registro
23/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/03/2021
Última transação
24/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
5
Tipo de titular
03
Localização do titular
Mississauga, Ontario, CA
Examinador
MORENO, PAUL A
Unidade examinadora
L30
Localização atual
TMEG LAW OFFICE 103
Descrição da marca
The mark consists of the word "EVOLVE" in stylized lettering with the "V" forming into the "O" with the word "BIOLOGICS" underneath the letters "LVE" in stylized format.
Titulares e representantes
Titulares
EVOLVE BIOLOGICS INC.
Therapure Biopharma Inc.
Representantes
Christopher J. Schulte MERCHANT & GOULD P.C.
Classificação técnica
Classes Nice
Classe 5Classe 37Classe 40Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate for human clinical useplasma protein fractionsserum albuminimmunoglobulinscoagulation factorsantihemophilic factorsclotting factorsenzymescoenzymescoactivatorsinhibitorsstructural proteins; resinsfor medical usepolysaccharide beads cross-linked to ligands for capturing proteins from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate using chromatographic methods
Classe 37
Construction of biotechbiopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities
Classe 40
Contract manufacturing services for others for biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate for research and developmentclinical use; consulting services concerning manufacturing of biologics
Classe 41
Educational servicesdesigningarrangingconducting training programs for research and developmentmanufacturing of biologicsdesignconstructionuse of chromatography equipment
Classe 42
Development of pharmaceutical preparations and medicinesdevelopment services for others for the capture of biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate for research and developmentdesign and construction of chromatography equipmentdesign of biotechbiopharmaceutical and plasma manufacturing facilitiesscientific research and evaluationengineering; Design of biotechbiopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biolotics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate
Publicações
Histórico de despachos e eventos da marca no USPTO.
54 publicações encontradas
CORV
REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
07/07/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/07/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/07/2021
ES7R
TEAS SECTION 7 REQUEST RECEIVED
19/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
23/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/01/2021
PUBO
PUBLISHED FOR OPPOSITION
05/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/12/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/07/2020
GNRT
NON-FINAL ACTION E-MAILED
06/07/2020
CNRT
NON-FINAL ACTION WRITTEN
06/07/2020
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
25/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/02/2020
GNRT
NON-FINAL ACTION E-MAILED
12/02/2020
CNRT
NON-FINAL ACTION WRITTEN
12/02/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
28/01/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
14/01/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/01/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
30/12/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
27/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/12/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
13/12/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
27/11/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
30/10/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
19/06/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
19/06/2019
CNSI
SUSPENSION INQUIRY WRITTEN
19/06/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
30/11/2018
GNSL
LETTER OF SUSPENSION E-MAILED
30/11/2018
CNSL
SUSPENSION LETTER WRITTEN
30/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
30/10/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/05/2018
GNSL
LETTER OF SUSPENSION E-MAILED
03/05/2018
CNSL
SUSPENSION LETTER WRITTEN
03/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2018
ALIE
ASSIGNED TO LIE
01/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/04/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/02/2018
GNRT
NON-FINAL ACTION E-MAILED
16/02/2018
CNRT
NON-FINAL ACTION WRITTEN
16/02/2018
DOCK
ASSIGNED TO EXAMINER
14/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/12/2017
NWAP
NEW APPLICATION ENTERED
15/12/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EVOLVE BIOLOGICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.